5 research outputs found
Baseline characteristics of patients before and after matching.
<p>*/**Statistical significance of differences between groups was tested by the ML chi-square test for categorical variables and by the independent Student’s <i>t</i>-test for continuous variables</p><p>*/**p<0.05/p<0.001</p><p><sup>a</sup>Parameter used in a logistic regression model of a propensity score</p><p><sup>b</sup>Parameter was not known for all patients, and statistics were computed on a reduced basis</p><p><sup>c</sup>Medication at discharge was computed on patients who were alive after discharge</p><p>LVEF—left ventricular ejection fraction, BP—blood pressure, MI—myocardial infarction, TIA—transient ischemic attack, PCI—percutaneous coronary intervention, CABG—coronary artery bypass graft, PM—pacemaker, ICD—implantable cardioverter–defibrillator, CRT—cardiac resynchronization therapy, COPD—chronic obstructive pulmonary disease, ARB—angiotensin-2 receptor blockers.</p><p>Baseline characteristics of patients before and after matching.</p
Baseline characteristics of patients after matching according to type of heart failure.
<p>*/**Statistical significance of differences between groups tested by the ML chi-square test for categorical variables and by the independent Student’s <i>t</i>-test for continuous variables</p><p>*/**p<0.05/p<0.001</p><p><sup>a</sup>Parameters used in a logistic regression model of a propensity score</p><p><sup>b</sup>Medication at discharge was computed on patients who were alive after discharge</p><p>LVEF—left ventricular ejection fraction, BP—blood pressure, MI—myocardial infarction, TIA—transient ischemic attack, PCI—percutaneous coronary intervention, CABG—coronary artery bypass graft, PM—pacemaker, ICD—implantable cardioverter–defibrillator, CRT—cardiac resynchronization therapy, COPD—chronic obstructive pulmonary disease, ARB—angiotensin-2 receptor blockers.</p><p>Baseline characteristics of patients after matching according to type of heart failure.</p
Thirty-day mortality according to the BMI category and type of heart failure.
<p>Thirty-day mortality according to the BMI category and type of heart failure.</p
Long-term mortality for all patients according to a BMI of 25 kg/m<sup>2</sup> in a non-balanced and balanced dataset and for ADHF and <i>de novo</i> AHF patients.
<p>Long-term mortality for all patients according to a BMI of 25 kg/m<sup>2</sup> in a non-balanced and balanced dataset and for ADHF and <i>de novo</i> AHF patients.</p